4//SEC Filing
Smith Michael Alexander 4
Accession 0001870278-25-000009
CIK 0001104506other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:26 PM ET
Size
32.2 KB
Accession
0001870278-25-000009
Insider Transaction Report
Form 4
INSMED IncINSM
Smith Michael Alexander
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-02$141.16/sh−1,354$191,131→ 77,820 total - Sale
Common Stock
2025-09-02$145.18/sh−4,944$717,770→ 56,085 total - Sale
Common Stock
2025-09-02$144.16/sh−8,300$1,196,528→ 61,029 total - Exercise/Conversion
Common Stock
2025-09-02$30.46/sh+12,780$389,279→ 79,174 total - Sale
Common Stock
2025-09-02$145.89/sh−1,183$172,588→ 54,902 total - Sale
Common Stock
2025-09-02$142.06/sh−1,100$156,266→ 76,720 total - Exercise/Conversion
Stock Option (right to buy)
2025-09-02−12,780→ 0 totalExercise: $30.46Exp: 2028-01-04→ Common Stock (12,780 underlying) - Sale
Common Stock
2025-09-02$143.16/sh−7,391$1,058,096→ 69,329 total
Footnotes (8)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This is the weighted average sales price representing 1,354 shares sold at prices ranging from $140.58 to $141.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F3]This is the weighted average sales price representing 1,100 shares sold at prices ranging from $141.58 to $142.55 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F4]This is the weighted average sales price representing 7,391 shares sold at prices ranging from $142.70 to $143.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F5]This is the weighted average sales price representing 8,300 shares sold at prices ranging from $143.72 to $144.71 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F6]This is the weighted average sales price representing 4,944 shares sold at prices ranging from $144.72 to $145.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F7]This is the weighted average sales price representing 1,183 shares sold at prices ranging from $145.75 to $146.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F8]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001870278
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 5:26 PM ET
- Size
- 32.2 KB